Is a complete BDSX research report available?

No complete published report is available for Biodesix, Inc. (BDSX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Biodesix, Inc. (BDSX)

NASDAQ: BDSX · USD

$22.4

+0.47 (+2.1%)· Recorded snapshot

Market cap	236.6M
Revenue (ttm)	102.9M
Net income (ttm)	-27.8M
EPS (ttm)	-$3.13
Shares out	10.6M
Volume	94,898
Beta	0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 102.9M
Net income (ttm): -27.8M
EPS (ttm): -$3.13
Market cap: 236.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001439725
Company name	Biodesix, Inc.
Country	United States
Country code	US
CUSIP number	09075X207
Earnings date	2026-11-05
Earnings time	amc
Employees	334
Employees change	61
Employees growth	22.34%
Enterprise value	$278.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
Industry	Diagnostics & Research
IPO date	2020-10-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US09075X2071
Last 10-K release date	2026-02-26
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2025-09-15
Last stock split type	Reverse
Market cap	$236.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	No
Price	$22.42
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	BDSX
U.S. state	Colorado
Website	https://www.biodesix.com

Metric

Value

Amount currency

USD

CIK code

0001439725

Company name

Biodesix, Inc.

Country

United States

Country code

CUSIP number

09075X207

Earnings date

2026-11-05

Earnings time

amc

Employees

334

Employees change

Employees growth

22.34%

Enterprise value

$278.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

Industry

Diagnostics & Research

IPO date

2020-10-28

Is primary listing

Yes

Is SPAC

ISIN number

US09075X2071

Last 10-K release date

2026-02-26

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2025-09-15

Last stock split type

Reverse

Market cap

$236.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-05

Options

Price

$22.42

Price currency

USD

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

BDSX

U.S. state

Colorado

Website

https://www.biodesix.com

Metric	Value
Earnings yield	-13.94%
EV/Sales	2.68x
FCF / EV yield	-7.34%
FCF yield	-8.66%
Forward EV/Sales	2.26x
Forward P/S	1.92x
Industry forward P/E	30.92x
Industry P/E	50.57x
P/B ratio	25.32x
P/S ratio	2.27x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-13.94%

EV/Sales

2.68x

FCF / EV yield

-7.34%

FCF yield

-8.66%

Forward EV/Sales

2.26x

Forward P/S

1.92x

Industry forward P/E

30.92x

Industry P/E

50.57x

P/B ratio

25.32x

P/S ratio

2.27x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-19.99%
EBITDA margin	-14.58%
Gross margin	82.5%
Operating margin	-19.99%
Pretax margin	-26.97%
Profit margin	-26.97%
Profit per employee	$-83,120
Revenue per employee	$308,201
ROA	-14.05%
ROA (5Y)	-25.95%
ROCE	-25.72%
ROE	-540.01%
ROE (5Y)	-320.15%
ROIC	-16.68%
SBC / revenue	3.95%

Metric

Value

EBIT margin

-19.99%

EBITDA margin

-14.58%

Gross margin

82.5%

Operating margin

-19.99%

Pretax margin

-26.97%

Profit margin

-26.97%

Profit per employee

$-83,120

Revenue per employee

$308,201

ROA

-14.05%

ROA (5Y)

-25.95%

ROCE

-25.72%

ROE

-540.01%

ROE (5Y)

-320.15%

ROIC

-16.68%

SBC / revenue

3.95%

Metric	Value
EPS growth quarters	17
EPS growth years	7
Gross profit growth	40.84%
Gross profit growth (Q)	37.87%
Gross profit growth 3Y	44.25%
Gross profit growth 5Y	20.72%
Net income growth quarters	4
Net income growth years	3
Revenue growth	34.46%
Revenue growth (Q)	34.18%
Revenue growth (QoQ)	5.11%
Revenue growth 3Y	35.21%
Revenue growth 5Y	5.99%
Revenue growth quarters	16
Revenue growth years	3

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

40.84%

Gross profit growth (Q)

37.87%

Gross profit growth 3Y

44.25%

Gross profit growth 5Y

20.72%

Net income growth quarters

Net income growth years

Revenue growth

34.46%

Revenue growth (Q)

34.18%

Revenue growth (QoQ)

5.11%

Revenue growth 3Y

35.21%

Revenue growth 5Y

5.99%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-412,000
Depreciation and amortization	$5.6M
EBIT	$-20.6M
EBITDA	$-15M
EPS	$-3.13
FCF per share	$-1.92
Financing cash flow	$29.7M
Free cash flow	$-20.2M
Free cash flow minus SBC	$-24.3M
Gross profit	$84.9M
Investing cash flow	$-569,000
Net borrowing	$-15,000
Net cash flow	$9.3M
Net income	$-27.8M
Operating cash flow minus SBC	$-23.9M
Operating income	$-20.6M
Revenue	$102.9M
Stock-based compensation	$4.1M

Metric

Value

Capital expenditures

$-412,000

Depreciation and amortization

$5.6M

EBIT

$-20.6M

EBITDA

$-15M

EPS

$-3.13

FCF per share

$-1.92

Financing cash flow

$29.7M

Free cash flow

$-20.2M

Free cash flow minus SBC

$-24.3M

Gross profit

$84.9M

Investing cash flow

$-569,000

Net borrowing

$-15,000

Net cash flow

$9.3M

Net income

$-27.8M

Operating cash flow minus SBC

$-23.9M

Operating income

$-20.6M

Revenue

$102.9M

Stock-based compensation

$4.1M

Metric	Value
Altman Z-Score	-6.16
Book value per share	$0.87
Debt / equity	7.85
Goodwill	$15M
Interest coverage	-2.54
Long-term assets	$51.8M
Long-term liabilities	$70.9M
Net cash (debt)	$-41.8M
Net cash / market cap	-17.88%
Net debt / equity	4.57
Piotroski F-Score	4
Property, plant and equipment	$29.6M
Shareholders' equity	$9.1M
Tangible book value	$-8.9M
Tangible book value per share	$-0.84
Total assets	$95.3M
Total cash	$30M
Total debt	$71.8M
Total liabilities	$86.2M
WACC	7.67%

Metric

Value

Altman Z-Score

-6.16

Book value per share

$0.87

Debt / equity

7.85

Goodwill

$15M

Interest coverage

-2.54

Long-term assets

$51.8M

Long-term liabilities

$70.9M

Net cash (debt)

$-41.8M

Net cash / market cap

-17.88%

Net debt / equity

4.57

Piotroski F-Score

Property, plant and equipment

$29.6M

Shareholders' equity

$9.1M

Tangible book value

$-8.9M

Tangible book value per share

$-0.84

Total assets

$95.3M

Total cash

$30M

Total debt

$71.8M

Total liabilities

$86.2M

WACC

7.67%

Metric	Value
Asset turnover	1.12
Current assets	$43.6M
Current liabilities	$15.3M
Current ratio	2.85
Inventory turnover	12.86
Net working capital	$-113,000
Quick ratio	2.56
Working capital	$28.3M
Working capital turnover	4.52

Metric

Value

Asset turnover

1.12

Current assets

$43.6M

Current liabilities

$15.3M

Current ratio

2.85

Inventory turnover

12.86

Net working capital

$-113,000

Quick ratio

2.56

Working capital

$28.3M

Working capital turnover

4.52

Metric	Value
Buyback yield / dilution	-21.27%
Dividend yield	0%
Shareholder yield	-21.27%

Metric

Value

Buyback yield / dilution

-21.27%

Dividend yield

Shareholder yield

-21.27%

Metric	Value
150-day SMA	$20.33
1D price change	2.14%
1M price change	-23.2%
1M total return	-23.2%
1W price change	-6.37%
1W total return	-6.37%
1Y price change	236.09%
1Y return CAGR	236.37%
1Y total return	236.09%
20-day SMA	$24.75
200-day SMA	$18.52
3M price change	0.59%
3M total return	0.59%
3Y price change	-19.6%
3Y return CAGR	-7.01%
3Y total return	-19.6%
50-day SMA	$26.48
50-day SMA vs 200-day SMA	50over200
52-week high	$31.97
52-week high date	2026-09-28
52-week low	$5.26
52-week low date	2026-01-09
5Y price change	-84.48%
5Y return CAGR	-31.11%
5Y total return	-84.48%
6M price change	120.74%
6M total return	120.74%
All-time high	$639.80
All-time high date	2021-01-20
All-time low	$3.44
All-time low date	2025-05-15
Average true range (ATR)	$1.85
Average volume	89.3K
Beta (1Y)	0.16
Beta (2Y)	0.34
Beta (5Y)	0.55
Change from 52-week high	-29.87%
Change from 52-week low	326.24%
Change from all-time high	-96.51%
Change from all-time low	550.47%
Change from open	5.01%
Day's gap	-2.73%
Dollar volume	$2.1M
High price	$22.72
Low price	$21.35
Monthly RSI	49.88
Open price	$21.35
Position in 52-week range	78.1%
Premarket change	-4.33%
Premarket close	$21.95
Premarket price	$21.00
Premarket volume	100
Previous close	$21.95
Price vs 150-day SMA	9.95%
Price vs 20-day SMA	-9.71%
Price vs 200-day SMA	20.67%
Price vs 50-day SMA	-15.6%
Relative volume	1.06
Return from IPO open	-91.85%
Return from IPO price	23.11%
RSI	37.82
Sharpe ratio	1.59
Sharpe ratio (3Y)	0.31
Sharpe ratio (5Y)	0.08
Sortino ratio	3.21
Sortino ratio (3Y)	0.57
Sortino ratio (5Y)	0.19
Volume	94.9K
Weekly RSI	51.77
YTD price change	228.68%
YTD total return	228.68%

Metric

Value

150-day SMA

$20.33

1D price change

2.14%

1M price change

-23.2%

1M total return

-23.2%

1W price change

-6.37%

1W total return

-6.37%

1Y price change

236.09%

1Y return CAGR

236.37%

1Y total return

236.09%

20-day SMA

$24.75

200-day SMA

$18.52

3M price change

0.59%

3M total return

0.59%

3Y price change

-19.6%

3Y return CAGR

-7.01%

3Y total return

-19.6%

50-day SMA

$26.48

50-day SMA vs 200-day SMA

50over200

52-week high

$31.97

52-week high date

2026-09-28

52-week low

$5.26

52-week low date

2026-01-09

5Y price change

-84.48%

5Y return CAGR

-31.11%

5Y total return

-84.48%

6M price change

120.74%

6M total return

120.74%

All-time high

$639.80

All-time high date

2021-01-20

All-time low

$3.44

All-time low date

2025-05-15

Average true range (ATR)

$1.85

Average volume

89.3K

Beta (1Y)

0.16

Beta (2Y)

0.34

Beta (5Y)

0.55

Change from 52-week high

-29.87%

Change from 52-week low

326.24%

Change from all-time high

-96.51%

Change from all-time low

550.47%

Change from open

5.01%

Day's gap

-2.73%

Dollar volume

$2.1M

High price

$22.72

Low price

$21.35

Monthly RSI

49.88

Open price

$21.35

Position in 52-week range

78.1%

Premarket change

-4.33%

Premarket close

$21.95

Premarket price

$21.00

Premarket volume

100

Previous close

$21.95

Price vs 150-day SMA

9.95%

Price vs 20-day SMA

-9.71%

Price vs 200-day SMA

20.67%

Price vs 50-day SMA

-15.6%

Relative volume

1.06

Return from IPO open

-91.85%

Return from IPO price

23.11%

RSI

37.82

Sharpe ratio

1.59

Sharpe ratio (3Y)

0.31

Sharpe ratio (5Y)

0.08

Sortino ratio

3.21

Sortino ratio (3Y)

0.57

Sortino ratio (5Y)

0.19

Volume

94.9K

Weekly RSI

51.77

YTD price change

228.68%

YTD total return

228.68%

Metric	Value
Float	5M
Float percentage	47.16%
Shares change (QoQ)	6.63%
Shares change (YoY)	21.27%
Shares held by insiders	40.86%
Shares held by institutions	29.39%
Shares outstanding	10.6M
Short % of float	4.06%
Short % of shares	1.91%
Short ratio	2.3 days

Metric

Value

Float

Float percentage

47.16%

Shares change (QoQ)

6.63%

Shares change (YoY)

21.27%

Shares held by insiders

40.86%

Shares held by institutions

29.39%

Shares outstanding

10.6M

Short % of float

4.06%

Short % of shares

1.91%

Short ratio

2.3 days

Biodesix, Inc. (BDSX)

Price

Financial snapshot

Fair-value bridge

Latest news · BDSX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BDSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BDSX

Frequently asked questions